Business
Currency:AUD
2024/FY
Stock NameRevenueRatio
Development of the Novosorb technology for use in a range of biodegradable medical devices103.19M100.00%
Region
Currency:AUD
2024/FY
Stock NameRevenueRatio
United States Of America79.84M77.37%
Other countries16.8M16.28%
Australia and New Zealand6.56M6.36%